Inovio Jumps After Announcing Successful Zika, MERS Vaccine Studies – Benzinga02/23/2017BenzingaInovio Jumps After Announcing Successful Zika, MERS Vaccine StudiesBenzingaInovio Pharmaceuticals, Inc. (NASDAQ: INO) said Thursday it's observed a 100-percent antibody response in a phase I study for a Zika virus vaccine and a 92 percent antibody response in a phase […]